Cr. Platasalaman et al., BRAIN CYTOKINE MESSENGER-RNAS IN ANORECTIC RATS BEARING PROSTATE ADENOCARCINOMA TUMOR-CELLS, American journal of physiology. Regulatory, integrative and comparative physiology, 44(2), 1998, pp. 566-573
Cancer is consistently associated with anorexia. The Lobund-Wistar rat
model of prostate cancer exhibits clinical manifestations (including
anorexia) that resemble many aspects of the human disease. Cytokines a
re proposed to be involved in cancer-associated anorexia. Here we inve
stigated mRNA profiles of feeding-modulatory cytokines and neuropeptid
es in specific brain regions of anorectic Lobund-Wistar rats bearing p
rostate adenocarcinoma tumor cells. Interleukin (IL)-1 beta system com
ponents (ligand, signaling receptor, receptor accessory proteins, rece
ptor antagonist), tumor necrosis factor-alpha, transforming growth fac
tor-beta 1, glycoprotein 130 (IL-6 receptor signal transducer), proopi
omelanocortin (POMC, opioid peptide precursor), and neuropeptide Y (NP
Y) mRNAs were analyzed with sensitive and specific RNase protection as
says. The same brain region sample was assayed for all components. The
data show that early anorexia in tumor-bearing rats was associated wi
th an upregulation of IL-1 beta mRNA in the brain regions examined (ce
rebellum, cortex, and hypothalamus). IL-1 receptor antagonist (IL-1Ra)
mRNA and IL-1 receptor type I mRNA levels were also significantly inc
reased in the cortex and hypothalamus. All other cytokine components,
POMC, or NPY mRNA levels were not significantly different between tumo
r-bearing and pair-fed (control) rats. IL-1 beta mRNA and IL-1Ra mRNA
were also significantly upregulated in the spleen of tumor-bearing rat
s. These data suggest that 1) IL-1 beta mRNA upregulation in the brain
may be relevant to the anorexia exhibited by the tumor-bearing Lobund
-Wistar rat and 2) in vivo characterization of cytokine components in
discrete brain regions during cancer is necessary to understand underl
ying molecular mechanisms responsible for cancer-associated neurologic
al manifestations.